AbbVie Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (154)

Latest Posts

About This Stock More About This Stock
3 Dividend Stocks To Buy For Second Half Of 2020 For Coronavirus Safety
Article By: Zacks Investment Research
Wednesday, July 1, 2020 3:52 AM EDT
Stocks climbed in morning trading on the last day of the second quarter to finish off what has been a wild three-month stretch for the market.
In this article: LMT, MSFT, ABBV Also: BA, DIS, LLY, MRK, NOC, PFE, AAPL, AMZN, ZM
Read
Bank On These 2 Safe Healthcare Stocks In Crazy Times
Article By: Tom Hutchinson
Friday, June 26, 2020 2:50 PM EDT
Amid a global health crisis and a very uncertain market, safe healthcare stocks should be part of your portfolio.
In this article: LLY, ABBV
Read
Here Are Three Of My Favorite Dividend Plays – Including One With A 7.4% Yield
Article By: Shah Gilani
Wednesday, June 24, 2020 5:15 AM EDT
Thanks to the COVID-19 pandemic, 40 S&P 500 companies suspended dividends, and another 18 cut them completely in the first five months of the year.
In this article: VZ, WFC, ABBV
Read
AbbVie Stock: Is It REALLY One Of The Best Value Stocks In 2020?
Video By: Kiana Danial
Thursday, June 11, 2020 2:32 AM EDT
Many Wall Street investors have ranked AbbVie in the top 10 value stocks among the best dividend stocks 2020. The AbbVie stock erased the COVID-19 related losses on June 9th, 2020. Now the question is, what’s next for this stock in terms of price.
In this video: ABBV
Watch
2 High-Yield Stocks For The Next Phase Of The Market
Article By: Tom Hutchinson
Wednesday, April 15, 2020 12:15 PM EDT
It’s time to start looking toward a post-coronavirus market and economy. And these two high-yield stocks are well-positioned for the coming recovery.
In this article: ABBV, VZ Also: AGN, T, AMZN, NFLX
Read

PARTNER HEADLINES

Latest Tweets for $ABBV

No tweets yet!

$ABBV

Macy’s Q1 Was Bad, But The Company Has The Cash To Survive The Current Pandemic
Jonathan Weber 7/3/2020 4:06:07 PM

Glad you liked it Sheryl! Right now I think a range of REITs and healthcare stocks are attractive from a risk-reward standpoint, including $ABBV, $BMY, $O, $SLG, $SPG, etc.

AbbVie: Is This Biopharma Giant’s 6% Yield Safe?
Beating Buffett 7/11/2019 1:00:14 PM

How much debt does $ABBV have?

AbbVie Has It All: Growth, Dividend Growth And Compelling Valuation
Dan Richards 6/25/2019 11:19:59 PM

$ABBV certainly sounds like a great buy.

AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 4 of 4 comments